Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

value $0.01 per

share, authorized 90,000,000 shares,

issued 36,460,461 and 35,901,276

shares 364 359

Additional paid-in-capital 274,963 254,013

Retained earnings 230,195 180,298

Accumulated other comprehensive

loss (1,362) (431)

Treasury stock, at cost 2,604,977

and 889,245 shares (66,405) (33,188)

Total stockholders' equity 437,755 401,051

Total liabilities and stockholders'

equity $781,523 $814,677

PAR PHARMACEUTICAL COMPANIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In Thousands, Except Per Share Data)

(Unaudited)

Three months ended Twelve months ended

December 31, December 31, December 31, December 31,

2007 2006 2007 2006

Revenues:

Net product sales $149,494 $176,807 $739,020 $705,378

Other product

related revenues 5,646 6,826 30,646 19,790

Total revenues 155,140 183,633 769,666 725,168

Cost of goods sold 97,293 124,680 501,147 507,220

Gross margin 57,847 58,953 268,519 217,948

Operating expenses:

Research and

development 16,528 18,459 77,659 62,442

Selling, general and

administrative 37,751 37,152 138,217 148,488

Intangible assets

impairment - 1,100 - 1,100

Settlements, net - - (945) 1,
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-FirstCall/--TheAdvisoryBoardCompany(Nasdaq:...tAnnualPiperJaffrayHealthCareConferenceinNewYorkCi...M(EST),willbetheCompany,sChiefExecutiveOfficer,Rob...cer,MichaelT.Kirshbaum.Thepresentationmaterialswil...ww.advisoryboardcompany.com ,throughDecember16,200...
(Date:11/25/2009)...RNewswire/--DanielTouizer,CEOof Ci n e r gyHe...nsurancebenefitprograms,isconcernedthatthelabordep...fiveAmericansarewithoutafull-timejobandunlikelytoh...edeterminedbytheU-6number,whichhasspikedto17.5%,th...izer ."Thesestatisticsarealarmingasitmeansthatman...
(Date:11/25/2009)... Melvin R. Kaplan, MD, FACP, a former Board Chair ...that became Los Angeles Biomedical Research Instit...l be honored by the American College of Physicians.... , At its April 22, 2010 meeting in Toronto, th...Kaplan with the Ralph O. Claypoole Sr. Memorial Aw...
(Date:11/25/2009)... success for patients with liver lesions, research...ay News) -- Adding the drug cetuximab to neoadjuva...ds of successful surgery in colorectal cancer pati... research suggests. , , Tumors spread to other...ith colorectal cancer. Most commonly, the cancer s...
(Date:11/25/2009)...PRNewswire-FirstCall/-- TheProvidenceServiceCorpo...aresubsidiary,thenation,slargestcoordinatorofnon-e...iceofawardfromtheStateofFloridaCommissionfortheTra...encytransportationservicestobothMiami-DadeandVolus...revenueovertheinitial18monthterm,issubjecttofinali...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3
...r, researchers studying eight cross-gender heart t...overed that the body can actively reshape the hear...tanding belief that the heart cannot repair itself...er organs came after Dr. Federico Quaini and his c...
... amount of fruit and vegetables, but they are stil...ruits and vegetables acts as a booster to our huma...g fruit and veg// at least five times a day increa...ase was from 20 per cent to 25 per cent during thi...
...eath in the United States, after heart disease and...ry year, and 167,000 die from it. Men who suffer f...es as likely// to die from a stroke as other men. ...r 14 years.They found the men with depression or s...
...larly women, may have an increased risk of develop...chers studied almost 100,000 patients who had been... the patients showed any signs of cancer at their ...study’s conclusion, the researchers found that lun...
...rt all reduce the risk of Alzheimer's disease, acc...attainment has already been associated with reduce...eisure activities, too, protect against cognitive ... the participants about their intellectual, social...
...uring her pregnancy, the special form of the disea...and her baby at risk. Moms can develop high blood ...risk for lung problems and occasionally die. To ke... Researchers in Australia and New Zealand found t...
Other Medicine News:
(Date:11/25/2009)...v.25/PRNewswire/--SwissrayInternational,Inc.aleadi...tems,announcedtodaythatitsoperationshavebeenacquir...rowingSwissray,smedicalimagingbrand.Theacquisition...ontractsandinventory.After25yearsofsuccessandgrowt...gicaladvancementswithstableandsteadygrowth. ,, ...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...ewswire/-- ,, WHAT:RomHoubens,aBelgianmanthough...,wasactuallyfullyconsciousandawakeduringthattimean...VoxEyeMaxwasfeaturedinthesegmenttoillustratehowpeo...kcommunication. ,, WHEN:GoodMorningAmerica-- Tu...ech.com ,, WHO:RomHoubenswasanengineeringst...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 3Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 1IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 2
...loping Embryonic Stem Cell Lines for Therapeutic ...C., Jan. 17 A California research team has,become...the cloning of a,human embryo using donated oocyte...onor. The study was published online today by the ....com/cgi-bin/prnh/20080117/CLTH022LOGO ), The ex...
...Vical Incorporated,(Nasdaq: VICL ) today announce...AnGes MG, Inc. for costs associated with the ongoi...c Melanoma (AIMM) Phase 3 trial., AnGes is fundin...er a,previously announced collaborative agreement ...uity investments totaling $22.6 million, for which...
Other Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 2Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 3
Coolscope
Eclipse E400
...e the slight change in the difficulty score for ea...orrected visual acuity examinations of 7420 eyes d...lty scores were derived from the examination of 23...letters which resulted in the ultimate homogeneity...
Cube Stereogram Stereo Test
Medicine Products: